ONE OF THE CAROLINAS’ MOST EXPERIENCED LASIK AND CATARACT SURGEONS

Scott W. Tunis MD FACS

To provide you with state of the art technology in medicine and surgery of the eye, through a personalized and compassionate approach, while drawing on the experience of thousands of procedures over 30 years of practice.

Scott W. Tunis MD FACS is a Board Certified Ophthalmologist and a Fellow of the American College of Surgeons. He specializes in LASIK and laser vision correction procedures and is a recognized specialist in cataract surgery and corneal disease. He holds two United States Patents in intraocular lens implant technology and was involved in the FDA studies for myopic LASIK.

In 2010, he was named to the highly selective group of “Premier Surgeons” by Ocular Surgery News, recognizing him as one of only 250 eye surgeons in the United States who are considered innovators and leaders in the field of premium cataract surgery.

About Dr. Scott Tunis

Credentials

Amherst College BA 1977
University of Virginia School of Medicine MD 1981
Medical University of South Carolina Residency in Ophthalmology 1985
Board Certified, American Board of Ophthalmology 1987
Fellow, American Academy of Ophthalmology
Fellow, American College of Surgeons
Member, American Society of Cataract and Refractive Surgery
Consumer’s Research Council, America’s Top Ophthalmologists
2010 PS250 Premier Surgeon – one of the 250 Top Innovators in Premium IOL Surgery
2016 PS300 Premier Surgeon – one of the 300 Top Innovators in Premium IOL Surgery

Practice Experience

One of the Carolinas’ most experienced LASIK Surgeons with over 25 years LASIK experience and more than 30,000 LASIK procedures performed
30+ years Cataract surgery experience with more than 30,000 Cataract procedures performed
Holder of two United States Patents in Intraocular Lens Implant Technology: US Patents 5549614 and 5556400
Past Chief of Ophthalmology, Holy Cross Hospital, Fort Lauderdale, FL
Past Chief of Ophthalmology, New Hanover Regional Medical Center, Wilmington, NC
Medical Director, Spare-Specs, LLC
President, Medical Director and Founder, Lenstatin LLC
Principal Investigator, “The Post-Vitrectomy Lenstatin Study”: A Prospective Randomized Double Blind Human Clinical Trial Testing the Efficacy of Lenstatin in Inhibiting Cataract Formation and Progression After Pars Plana Vitrectomy : ClinicalTrials.gov Identifier NCT02131194

Services

LASIK, PRK, and Laser Vision Correction

Cataract Surgery with Intraocular Lens Implantation

Premium, Multifocal, Refractive, and Clear Lens Implantation

Corneal Refractive Surgery, Astigmatism Correction, Monovision

We are a participating provider with most major government and private insurance carriers. Co-payments, deductibles, and fees for non-covered services are due at the time of your visit.

Learn More About Financing Options